Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $912.5 billion, total revenue of $176.42 billion and a weighted average PE ratio of 47.26.
Market Cap
912.5B
Revenue
176.42B
Profits
19.31B
PE Ratio
47.26
Profit Margin
10.94%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 251.87B | -3.74% | 1,079,582 | 47.35B |
| 2 | DHR | Danaher Corporation | 159.81B | -3.31% | 2,067,421 | 25.61B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 52.75B | -4.15% | 434,910 | 4.66B |
| 4 | NTRA | Natera, Inc. | 51.16B | -9.23% | 1,442,519 | 2.71B |
| 5 | A | Agilent Technologies, Inc. | 48.36B | -3.19% | 1,318,748 | 7.37B |
| 6 | WAT | Waters Corporation | 44.47B | -3.20% | 552,135 | 5.61B |
| 7 | IQV | IQVIA Holdings Inc. | 43.06B | -0.94% | 685,833 | 17.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 33.56B | -2.79% | 154,337 | 4.13B |
| 9 | ILMN | Illumina, Inc. | 31.15B | -9.05% | 2,854,235 | 4.54B |
| 10 | LH | Labcorp Holdings Inc. | 29.23B | -2.14% | 310,958 | 14.59B |
| 11 | DGX | Quest Diagnostics Incorporated | 27.68B | -1.59% | 325,069 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 20.63B | -8.79% | 2,265,118 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.90B | -2.54% | 142,706 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 16.98B | -4.57% | 868,366 | 2.94B |
| 15 | CRL | Charles River Laboratories International, Inc. | 15.07B | -3.50% | 900,685 | 3.98B |
| 16 | ICLR | ICON Public Limited Company | 14.86B | -2.36% | 585,395 | 8.23B |
| 17 | QGEN | Qiagen N.V. | 10.49B | -0.22% | 2,621,936 | 2.12B |
| 18 | RDNT | RadNet, Inc. | 6.14B | -2.87% | 493,720 | 2.27B |
| 19 | GRAL | GRAIL, Inc. | 5.34B | -16.80% | 1,402,601 | 166.60M |
| 20 | BLLN | BillionToOne, Inc. | 5.12B | -4.79% | 1,203,150 | 436.87M |
| 21 | SHC | Sotera Health Company | 4.57B | -2.38% | 855,779 | 1.23B |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.13B | -3.18% | 2,546,684 | 298.01M |
| 23 | CDNA | CareDx, Inc. | 4.03B | -10.77% | 1,273,415 | 497.40M |
| 24 | NEO | NeoGenomics, Inc. | 2.09B | -5.89% | 1,253,960 | 787.75M |
| 25 | WGS | GeneDx Holdings Corp. | 1.86B | -10.14% | 434,987 | 454.43M |
| 26 | VCYT | Veracyte, Inc. | 1.81B | -57.10% | 10,136,447 | 581.78M |
| 27 | PSNL | Personalis, Inc. | 1.67B | -1.20% | 2,363,438 | 80.77M |
| 28 | OPK | OPKO Health, Inc. | 1.26B | -4.80% | 4,949,516 | 654.10M |
| 29 | FRNM | Freenome, Inc. | 1.13B | -6.64% | 801,741 | 35.41M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.04B | -4.34% | 231,271 | 357.28M |
| 31 | MYGN | Myriad Genetics, Inc. | 586.33M | 1.83% | 2,023,034 | 803.60M |
| 32 | FLGT | Fulgent Genetics, Inc. | 511.78M | -5.49% | 140,394 | 323.93M |
| 33 | BDSX | Biodesix, Inc. | 206.80M | -8.79% | 79,442 | 102.94M |
| 34 | XGN | Exagen Inc. | 185.08M | -10.22% | 272,464 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 139.74M | 3.27% | 82,988 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 79.52M | -8.30% | 76,883 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 56.42M | -9.67% | 543,648 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 34.19M | -2.40% | 14,895 | 27.20M |
| 39 | MDXH | MDxHealth SA | 14.13M | -5.31% | 808,393 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 6.89M | -7.01% | 14,169 | - |
| 41 | XWEL | XWELL, Inc. | 5.10M | -0.73% | 29,420 | 28.28M |
| 42 | BIAF | bioAffinity Technologies, Inc. | 3.40M | -9.56% | 56,955 | 5.90M |
| 43 | ADVB | Advanced Biomed Inc. | 3.06M | -11.67% | 19,487 | 127.64K |
| 44 | ISPC | iSpecimen Inc. | 2.01M | -5.10% | 101,084 | 466.30K |